The honeymoon ends at month three. Month four is when the work actually starts. Most partnerships never make it past that transition.
I’ve seen this across every industry I’ve worked in — consulting, medtech, telecom, construction — and the pattern is so reliable I can almost predict which partnerships will fail just from the structure of the launch.
The Lifecycle
Here’s the pattern I’ve watched play out dozens of times:
Months 1-3: Announcement and enthusiasm.
Press release goes out. Executives take photos. Co-marketing assets get produced. Early joint calls have both teams engaged. Pipeline gets shared in a spreadsheet that looks impressive. Everyone is excited.
Months 4-6: Reality sets in.
The initial deals don’t close as fast as expected. Joint sales calls are harder to coordinate than internal ones. Each team’s reps revert to their owned-pipeline because that’s what their quota is tied to. Ownership gets fuzzy.
Months 6-12: Drift.
Nobody owns the joint motion. Quota conflicts emerge — whose number does this deal count toward? Strategic alignment at the executive level starts drifting. Quarterly business reviews get lighter. Joint pipeline reviews get skipped.
Months 12+: The partnership exists on paper.
Revenue never materialized. Nobody formally kills it because both sides still like the other logo on their website. Every 18 months someone from strategy asks “what’s going on with the X partnership?” Nobody has a clean answer.
The Failure Mode
The failure mode is almost always the same: nobody owned the joint motion after the executive honeymoon ended.
I’ve seen this most vividly in consulting, where two firms announce a strategic alliance and spend the first quarter actively sharing pipeline. Then each firm’s partners revert to their owned-revenue priorities — partnership deals are messier, margins are lower, and the spoils have to be split. The incentive structure pulls both sides back to their core business, and the partnership quietly fades.
Telecom channel partnerships have the same dynamic. The first six months have executive attention, co-selling agreements, joint training. Then executive attention moves elsewhere. The channel partners and direct sales teams compete for the same deals. Without active management, the conflict gets resolved by attrition — the partnership motion dies, direct sales wins by default, and the partnership becomes a logo slide at QBRs.
Medtech partnerships often die for a different but related reason: the partnership’s joint solution requires implementation effort that neither company’s services team was resourced for. Everyone agrees the joint offering is compelling. Nobody agrees on whose engineer is on-site when the customer has a problem.
What the Partnerships That Work Have In Common
Every partnership that actually delivers revenue — the ones I’ve watched work — has four things:
1. Named operators on both sides, not just sponsors.
Sponsors show up for the announcement. Operators show up weekly. The operator is the person whose day job is making the partnership work — and it should be a day job, not a 10% allocation to someone whose main role is something else. Partnerships run on 10% allocations don’t run. They drift.
2. A weekly or bi-weekly operating cadence.
Not a quarterly business review. A short, operational check-in where pipeline, blockers, and handoffs get worked through. If the meeting gets skipped, the partnership is dying — the meeting is the canary.
3. Joint pipeline review with explicit joint-accountability metrics.
Who’s responsible for each joint deal. What the next action is. What’s blocking. Which side is behind on their commitment. This is the conversation that’s awkward to have and easy to skip. Skip it, and the partnership dies without anyone noticing.
4. Explicit 90- and 180-day review checkpoints with kill criteria.
At 90 days and 180 days, review whether the partnership is hitting the joint metrics agreed at launch. If not, the kill criteria trigger an honest conversation: change the structure, change the scope, or wind it down.
The Diagnostic
For every active partnership you’re in right now, answer four questions:
- Who’s the named operator on their side and yours?
- When did you last have a formal ops review?
- What’s your joint pipeline, and what’s the win rate on it?
- What are the explicit kill criteria?
If you can’t answer those four questions cleanly, you already know how that partnership ends.
Without those four, what you have isn’t a partnership. It’s a press release with a long tail.